Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-06 @ 4:06 PM
Last Modification Date: 2025-12-17 @ 4:08 AM
Study NCT ID: NCT04877496
Protocol Section: NCT04877496
Start Identification Module Data
Brief Title: Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab.
Official Title: Registry Study for COVID19 Vaccination Efficacy in Patients With a Treatment History of Rituximab.
Acronym: RituxiVac
Organization: Insel Gruppe AG, University Hospital Bern
Organization Class: OTHER
Organization Study ID: 4749
Start Status Module Data
Status Verified Date: 2021-05
Overall Status: None
Study First Submit Date: 2021-05-06
Study First Submit QC Date:
Last Update Submit Date: 2021-05-27
Status: UNKNOWN
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Insel Gruppe AG University Hospital Bern
Lead Sponsor Class: OTHER
Lead Sponsor: Insel Gruppe AG University Hospital Bern
Start Oversight Module Data 372019
Description Module: 375519
Study Last Update Post Date Type(Status Module):
Attachment: Upload